Private Capital Group’s Takeda Pharmaceutical TAK Stock Holding History

Private Capital Group’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$27K	Buy	1,896 +31	+2%	+$443	0.02%	721
2022 Q1	$27K	Buy	1,865 +828	+80%	+$12.2K	0.01%	906
2021 Q4	$14K	Sell	1,037 -369	-26%	-$5.18K	﹤0.01%	1187
2021 Q3	$23K	Sell	1,406 -1,763	-56%	-$29.6K	0.01%	1014
2021 Q2	$53K	Sell	3,169 -370	-10%	-$6.3K	0.01%	651
2021 Q1	$65K	Sell	3,539 -1,575	-31%	-$28.3K	0.02%	529
2020 Q4	$93K	Buy	5,114 +2,155	+73%	+$37.8K	0.02%	528
2020 Q3	$53K	Sell	2,959 -649	-18%	-$11.8K	0.01%	683
2020 Q2	$65K	Buy	3,608 +708	+24%	+$12.7K	0.01%	595
2020 Q1	$44K	Buy	2,900 +1,062	+58%	+$19.2K	0.01%	705
2019 Q4	$36K	Sell	1,838 -64	-3%	-$1.22K	0.01%	878
2019 Q3	$33K	Buy	1,902 +1,521	+399%	+$26.3K	0.01%	963
2019 Q2	$8K	Sell	381 -1,521	-80%	-$27.7K	﹤0.01%	1484
2019 Q1	$39K	Buy	1,902 +1,326	+230%	+$26.7K	0.01%	899
2018 Q4	$10K	Buy	+576	New	+$9.72K	﹤0.01%	1402

Other funds holding TAK

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Private Capital Group's TAK Position: Q2 2022 in Review

Private Capital Group increased its Takeda Pharmaceutical (TAK) stake by 1.7% in Q2 2022, buying an estimated $443 and bringing the position to 1,896 shares worth $27K. The position accounts for 0.02% of the portfolio, ranked #721.

Private Capital Group first reported a position in TAK in Q4 2018 and has held it in 15 quarters since. The position peaked at $93K in Q4 2020. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2022.

Private Capital Group held 1,896 shares of Takeda Pharmaceutical worth $27K as of Q2 2022.
Private Capital Group bought 31 Takeda Pharmaceutical shares in Q2 2022, an estimated $443.
Takeda Pharmaceutical made up 0.02% of Private Capital Group's portfolio in Q2 2022, its #721 holding.
Private Capital Group first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 15 quarters since.
Private Capital Group's Takeda Pharmaceutical position peaked at $93K in Q4 2020.
283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.